GCGR and diabetes mellitus: In the mouse, targeted disruption of the GCGR gene results in reduced plasma glucose concentrations [11], [12] and treatment with GCGR antisense oligonucleotides has an antihyperglycemic effect in rodent models of diabetes [13], [14].